Gongwin Biopharm Holdings Co., Ltd. (TPEX: 6617)

Gongwin Biopharm Holdings Revenue

Gongwin Biopharm Holdings had revenue of 8.50M TWD in the quarter ending June 30, 2024, with 639.60% growth. This brings the company's revenue in the last twelve months to 31.71M, up 1,283.42% year-over-year. In the year 2023, Gongwin Biopharm Holdings had annual revenue of 18.92M with 1,554.86% growth.

• Revenue (ttm): 31.71M
• Revenue Growth: +1,283.42%
• P/S Ratio: n/a
• Revenue / Employee: n/a
• Employees: n/a
• Market Cap: 13.90B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	18.92M	17.77M	1,554.86%
Dec 31, 2022	1.14M	-	-
Dec 31, 2021	1.14M	310.00K	37.21%
Dec 31, 2020	833.00K	585.00K	235.89%
Dec 31, 2019	248.00K	186.00K	300.00%